Orlistat in the treatment of obesity

Expert Opinion on Pharmacotherapy - Tập 1 Số 4 - Trang 841-847 - 2000
Anne Ballinger1
1Digestive Diseases Research Centre, St Bartholomew's, Royal London School of Medicine and Dentistry, Turner Street, London, E1 2AD, UK. [email protected]

Tóm tắt

Từ khóa


Tài liệu tham khảo

PI-SUNYER FX, 1993, Ann. Intern. Med., 119, 655, 10.7326/0003-4819-119-7_Part_2-199310011-00006

THE NATIONAL HEART,, 1998, Arch. Intern. Med., 158, 1178

GOLDSTEIN DJ, 1992, Int. J. Obes., 6, 397

LUQUE CA, 1999, Ann. Pharmacother., 33, 968, 10.1345/aph.18319

KELLY SM, 1998, Br. J. Nutr., 80, 41, 10.1017/S0007114598001755

HEYMSFIELD SB, 1999, JAMA, 282, 1568, 10.1001/jama.282.16.1568

SJOSTROM L, 1998, Lancet, 352, 167, 10.1016/S0140-6736(97)11509-4

DAVIDSON MH, 1999, A randomized controlled trial. JAMA, 281, 235

ROSSNER S, 2000, European Orlistat Obesity Study Group. Obes. Res., 8, 49

HILL JO, 1999, Am. J. Cfin. Nutr., 69, 1108, 10.1093/ajcn/69.6.1108

HENSRUD DD, 2000, Clin. Perspect. Gastroenterol., 3, 50

HOLLANDER PA, 1998, Diabetes Care, 21, 1288, 10.2337/diacare.21.8.1288

NAGELE H, 1999, Eur. J. Clin. Pharmacol., 55, 667, 10.1007/s002280050690